| Document Date: 2015-03-30 23:15:54
Open Document File Size: 41,86 KBShare Result on Facebook
City Tokyo / Nagano / / Company Ajinomoto Pharmaceuticals Co. Ltd. / Kissei Pharmaceutical Co. Ltd. / Japan Ajinomoto Pharmaceuticals Co. Ltd. / / Continent Europe / / Country Germany / Japan / / Event Product Issues / FDA Phase / Business Partnership / / IndustryTerm pharmaceuticals / manufacturing / rectal foam product / conventional pharmaceuticals / foam type product / / MedicalCondition Abdominal pain / disease / government-designated intractable disease / GI disease / ulcerative colitis / inflammatory bowel diseases / diarrhea / / Organization Ltd. Corporate Planning Dept. PR Office / / Person Falk Pharma / Takashi Nagamachi / Mutsuo Kanzawa / / / Position President / Chairman & CEO / / Product AJM300 / response / /
SocialTag |
March 31, 2015 Ajinomoto Pharmaceuticals Co., Ltd. Kissei Pharmaceutical Co., Ltd. Ajinomoto Pharmaceuticals and Kissei announce partnership for joint development and marketing